LEXINGTON, Massachusetts,
May 25, 2017 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Flemming
Ornskov, MD, Chief Executive Officer, will participate at the
Jefferies Healthcare Conference in New
York City, NY on Thursday, June 8,
2017 at 3:00 PM EDT
(20:00 BST).
A live audio webcast will be available on the Presentations and
Webcasts section of Shire's Investor website at
http://investors.shire.com/. Subsequently, a replay of the webcast
will be available on this same website for approximately 90
days.
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on
serving people with rare diseases. We strive to develop
best-in-class products, many of which are available in more than
100 countries, across core therapeutic areas including Hematology,
Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders,
Gastrointestinal / Internal Medicine / Endocrine and Hereditary
Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to
develop and deliver breakthrough therapies for the hundreds of
millions of people in the world affected by rare diseases and other
high-need conditions, and who lack effective therapies to live
their lives to the fullest.
http://www.shire.com
For further information please
contact:
Investor Relations
Ian Karp
ikarp@shire.com
+1-781-482-9018
Robert Coates
rcoates@shire.com
+44-1256-894874
SOURCE Shire plc